TearLab to Present at the 19th Annual Rodman and Renshaw Global Investment Conference

SAN DIEGO, Sept. 11, 2017 -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (the “Company”), today announced that the company will be featured as a presenting company at the 19th Annual Rodman & Renshaw Global Investment Conference being held September 10-12, 2017 at the Lotte New York Palace Hotel in New York, NY.

TearLab’s management will provide a corporate overview and business update on the company during the presentation at the conference.

Details of the presentations are as follows:

The presentation will be webcast and available for replay in the Investor Section of TearLab’s website www.tearlab.com.

About TearLab Corporation

TearLab Corporation (www.tearlab.com) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System.  TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'.

Investor Contact:

The Ruth Group

Lee Roth

Tel: 646-536-7012

[email protected]